PACLITAXEL SERVYCAL

Paclitaxel 30, 100, 150 and 300 mg

SOLUTION FOR INJECTION

I.V. INFUSION

Sale under filed prescription

Made in Argentina

QUALI-QUANTITATIVE COMPOSITION

PACLITAXEL SERVYCAL 30 mg. Injectable.

Each 30mg.PACLITAXEL SERVYCAL vial contains:

PACLITAXEL 30mg, cremophor ELP 2635 mg, dehydrated alcohol quantity enough to 5.0 ml.

PACLITAXEL SERVYCAL 100 mg. Injectable.

Each 100mg. PACLITAXEL SERVYCAL vial contains:

PACLITAXEL 100mg, cremophor ELP 8783 mg, dehydrated alcohol quantity enough to. 16.7 ml.

PACLITAXEL SERVYCAL 150 mg. Injectable.

Each 150mg. PACLITAXEL SERVYCAL vial contains:

PACLITAXEL 150mg, cremophor ELP 13175 mg, dehydrated alcohol quantity enough to 25.0 ml.

PACLITAXEL SERVYCAL 300 mg. Injectable.

Each 300mg. PACLITAXEL SERVYCAL vial contains:

PACLITAXEL 300mg, cremophor ELP 26350 mg, dehydrated alcohol quantity enough to 50.0 ml.

THERAPEUTIC ACTION:

Paclitaxel is a natural, anti-tumor product.

INDICATIONS:

PACLITAXEL SERVYCAL is prescribed for the treatment of ovarian or breast metastatic carcinoma after standard therapy has failed.

PRESENTATION:

PACLITAXEL SERVYCAL 30. Injectable. PACLITAXEL: Packages containing one vial with concentrate for infusion.

PACLITAXEL SERVYCAL 100. Injectable. PACLITAXEL: Packages containing one vial with concentrate for infusion .

PACLITAXEL SERVYCAL 150. Injectable. PACLITAXEL: Packages containing one vial with concentrate for infusion .

PACLITAXEL SERVYCAL 300. Injectable. PACLITAXEL: Packages containing one vial with concentrate for infusion.

Store between 2 °C and 8 °C (refrigeration temperature) and protect from light.

Neither freezing nor refrigeration adversely affects the stability of the product.